World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02385539
Date of registration: 02/03/2015
Prospective Registration: No
Primary sponsor: Šaric, Jadranka Pavicic, M.D.
Public title: Intrathecal Administration of Levobupivacaine and Opioids in Elderly
Scientific title: Intrathecal Anesthesia for Elderly Patients Undergoing Surgery Lasting >45 Minutes: A Randomized, Controlled, Dose and Combination Finding Study
Date of first enrolment: January 2015
Target sample size: 240
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02385539
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).  
Phase:  N/A
Countries of recruitment
Croatia
Contacts
Name:     Jadranka Pavicic Šaric, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital Merkur
Key inclusion & exclusion criteria

Inclusion Criteria:

- male patients

- ASA II-III undergoing elective urological (transuretheral or transvesical
prostatectomy, hydrocelectomy, orchiectomy) or lower abdominal (inguinal
herniorrhaphy) surgery under spinal anesthesia requiring a sensory block to at least
the tenth thoracic dermatoma, lasting >45 minutes.

Exclusion Criteria:

- severe systemic disorders

- patients unwilling to accept regional anesthesia

- patients who will develope sensory block level lower than T10 dermatoma after
intrathecal injection

- patients with an abnormal coagulation profile or with significant pulmonary disease
(reactive airway disease or chronic obstructive pulmonary disease requiring daily
bronchodilator or steroid use and/or room air oxygen saturation <95% immediately
before surgery).



Age minimum: 65 Years
Age maximum: 95 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Adverse Reaction to Spinal Anesthetic
Intervention(s)
Drug: The impact of 10 independent variables on the likelihood of not developing hypotension after intrathecal injection.
Primary Outcome(s)
Optimal dose and combination of Levobupivacaine and Fentanyl or Sufentanil in elderly patients [Time Frame: 9 months]
Secondary Outcome(s)
Secondary ID(s)
JPAVSAR
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history